ArticleCells2024

PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer.

Sajid Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.